KELOWNA, BC, Nov. 13, 2018 /CNW/ - Valens GroWorks
Corp. (CSE: VGW) (OTC: MYMSF) (the "Company" or "Valens"), a multi-licensed, vertically integrated provider of
cannabis products and services focused on various proprietary extraction methodologies, distillation, cannabinoid isolation and
purification, as well as associated quality testing is pleased to announce it will begin trading, at market open today, on the
OTCQB® under the ticker symbol "MYMSF". Quotes and market information are now available at: www.otcmarkets.com/stock/MYMSF/quote
"We are excited to have finalized our new listing on the OTCQB® Marketplace. This new listing, combined with the current
work underway to finalize the Company's DTC eligibility, will increase Valens' presence with United
States investors, providing increased liquidity to the Company's growing shareholder base," says Tyler Robson, Valens CEO.
Valens' common shares continue to trade on the Canadian Securities Exchange under the symbol "VGW".
About Valens GroWorks
Valens GroWorks Corp. is a research-driven, vertically integrated Canadian cannabis company focused on downstream secondary
extraction methodology, distillation and cannabinoid isolation and purification, as well as associated quality testing with three
wholly-owned subsidiaries located in and around Kelowna, BC. Subsidiary Valens Agritech ("VAL") holds a standard processing and standard cultivation license class under the Cannabis
Act. VAL also has a supply agreement with Canopy Growth Corporation under their extensive CraftGrow distribution network.
Subsidiary Valens Labs is an ISO 17025 accredited cannabis testing lab providing sector-leading
analytical services and has partnered with Thermo Fisher Scientific to develop a Centre of Excellence in Plant Based Science.
Subsidiary Valens Farms is in the process of becoming a purpose-built facility in compliance with European Union (EU) Good
Manufacturing Practices (GMP) standards, ensuring the product from this facility can be exported anywhere in the world where
Cannabis is nationally legal for medical or adult usage purposes. For more information, please visit http://valensgroworks.com. The Company's investor deck can be found specifically
at http://valensgroworks.com/investors/
Notice regarding Forward Looking Statements
This news release contains certain "forward-looking statements" within the meaning of such statements under applicable
securities law. Forward-looking statements are frequently characterized by words such as "anticipates", "plan", "continue",
"expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed", "positioned" and
other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only
predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking
statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the
date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual
events or results to differ materially from those projected in the forward-looking statements. The Corporation is under no
obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a
result of new information, future events or otherwise, except as expressly required by applicable law.
The CSE or other regulatory authority has not reviewed, approved or disapproved the contents of this press release. We seek
Safe Harbour.
View original content to download multimedia:http://www.prnewswire.com/news-releases/valens-finalizes-listing-on-the-otcqb-300748646.html
SOURCE Valens GroWorks Corp.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/November2018/13/c3958.html